More recent studies have confirmed gender and age at exposure as highly significant factors in differential SMN risk with proton therapy (Armstrong et al., 2007 ; Zacharatou Jarlskog and Paganetti, 2008 ; Taddei et al., 2010 ).
← all excerpts
Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk.
1
—
—